Skip to main content
Log in

Safety of fluconazole in the treatment of vaginal candidiasis

A prescription-event monitoring study, with special reference to the outcome of pregnancy

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

A prescription-event monitoring (PEM) study has confirmed that fluconazole, a bis-triazole oral antifungal drug, is a safe and effective treatment for vaginal candidiasis. Useful information was available on 15,015 questionnaires returned by general practitioners. The events were compared with those recorded in PEM studies of itraconazole and 31 other drugs in a total of more than 330,000 patients.

The frequency of events in the study of itraconazole was almost identical. Upper respiratory tract and genitourinary infections were reported with above-average frequency but the relationship was with the disease being treated rather than the drug itself. No serious adverse effects were recorded with an unacceptably high incidence. None of the 125 deaths was caused by fluconazole. Although contraindicated for vaginal candidiasis in pregnancy, fluconazole was taken by 289 women at some time during the months before or during pregnancy; a follow-up study by questionnaire of the outcome of pregnancy showed fluconazole to be without harmful effect.

It is concluded that fluconazole is a well tolerated drug in the treatment of vaginal candidiasis and is associated with very few adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brammer KW (1989) Clinical experience with fluconazole in hospital practice. In: Richardson RG (ed) Fluconazole and its role in vaginal candidiasis. Royal Society of Medicine Services International Congress and Symposium Series No. 160. Royal Society of Medicine Services, London, pp 29–31

    Google Scholar 

  2. Multicentre Study Group (1988) Treatment of vaginal candidiasis with a single oral dose of fluconazole. Eur J Clin Microb Infect Diseases 7: 364–367

    Google Scholar 

  3. Kutzer E, Oittner R, Leodolter S, Brammer KW (1988) A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial. Eur J Obstet Gynaecol Reprod Biol 29: 305–313

    Google Scholar 

  4. Report of an International Multicentre Trial (1989) A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Br J Obstet Gynaecol 96: 226–232

    Google Scholar 

  5. Janssen PAJ, Symoens JE (1983) Hepatic reactions during ketoconazole treatment. Am J Med 74: 80–85

    Google Scholar 

  6. Hawkins Van Tyle J (1984) Ketoconazole. Pharmacotherapy 4: 343–373

    Google Scholar 

  7. Shaw JTB, Tarbit MH, Troke PF (1987) Cytochrome P-450 mediated sterol synthesis and metabolism: differences in sensitivity to fluconazole and other azoles. In: Fromtling RA (ed) Recent trends in the discovery, development and evaluation of anti-fungal agents. Prous, Barcelona, pp 125–139

    Google Scholar 

  8. Humphrey MJ, Jevons S, Tarbit MH (1985) Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans. Antimicrob Agents Chemother 28: 648–653

    Google Scholar 

  9. Inman WHW, Kubota K, Pearce GL, Wilton LV (1993) Fluconazole PEM Report No. 3. Drug Safety Research Unit, Southampton

    Google Scholar 

  10. Rubin PC, Wilton LV, Inman WHW (1992) Fluconazole and pregnancy: results of a prescription-event monitoring study, I. Int J Gynecol Obstetrics. 37 [Suppl]: 25–27

    Google Scholar 

  11. Matheson I, Soderman P, The Collaborative Group on Drug Use in Pregnancy (1989) Drug use in pregnancy. Preliminary results from Norway and Sweden (abstract). Eur J Clin Pharmacol 36: A 111

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inman, W., Pearce, G. & Wilton, L. Safety of fluconazole in the treatment of vaginal candidiasis. Eur J Clin Pharmacol 46, 115–118 (1994). https://doi.org/10.1007/BF00199872

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199872

Key words

Navigation